The brokerage said that Viking's obesity pipeline could help address two major challenges facing next-generation GLP-1 therapies: speed of efficacy and long-term patient adherence
Diagnosis: PCOS: increased pregnancy rates (15 RCTs, 1,908 women) Unexplained fertility: no difference in pregnancy rates (4 RCTs, 997 women) Tubal: no difference in pregnancy rates (2 RCTs, 71 women) Poor responders: no difference in pregnancy rates (1 RCT, 65 women) Poor ovarian reserve: no difference in pregnancy rates (2 RCTs, 266 women) Endometriosis: no difference in pregnancy rates (1 RCT, 280 women) Adverse events: Miscarriage: no difference (24 RCTs, 3,229 women) Multiple pregnancy: no difference (9 RCTs, 1,886 women) Ectopic pregnancy: no difference (7 RCTs, 308 women) Preterm birth: no difference (2 RCTs, 220 women) Placenta previa: no differences (1 RCT, 180 women) Preeclampsia: no difference (1 RCT, 160 women) N-acetyl-cysteine (NAC) NAC is a medication that can be used to treat Tylenol (acetaminophen) overdoses by increasing levels of the antioxidant glutathione
Sohal VS, Zhang F, Yizhar O, Deisseroth K
Chanoine JP, Hampl S, Jensen C
Understanding Hunger on GLP-1s And After Coming Off Them Share Why appetite feels different and how to bring back steadiness For many people, starting or stopping a GLP-1 medication brings noticeable shifts in appetite, fullness and eating rhythm
Alternatively, 1000mcg can be given daily SC/IM for 2-7 days, followed by maintenance treatment
